Lv3
260 积分 2024-04-09 加入
Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
1天前
待确认
Modeling the Exposure‐Response Relationship of Etanercept in the Treatment of Patients With Chronic Moderate to Severe Plaque Psoriasis
2天前
已完结
Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis
16天前
已完结
Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritis
21天前
已完结
Telitacicept: First Approval
22天前
已完结
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
29天前
已完结
Certolizumab pegol
29天前
已完结
Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis
29天前
已完结
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
1个月前
已完结
Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis
1个月前
已完结
皖公网安备34019202002308
